The VanR-VanS two-component system is responsible for inducing resistance to glycopeptide antibiotics in various bacteria. We have performed a comparative study of the VanR-VanS systems from two streptomyces strains, Streptomyces coelicolor and Streptomyces toyocaensis, to characterize how the two proteins cooperate to signal the presence of antibiotics and to define the functional nature of each protein in each strain background. The results indicate that the glycopeptide antibiotic inducer specificity is determined solely by the differences between the amino acid sequences of the VanR-VanS two-component systems present in each strain rather than by any inherent differences in general cell properties, including cell wall structure and biosynthesis. VanR of S. coelicolor (VanRsc) functioned with either sensor kinase partner, while VanR of S. toyocaensis (VanRst) functioned only with its cognate partner, S. toyocaensis VanS (VanSst). In contrast to VanRsc, which is known to be capable of phosphorylation by acetylphosphate, VanRst could not be activated in vivo independently of a VanS sensor kinase. A series of amino acid sequence modifications changing residues in the N-terminal receiver (REC) domain of VanRst to the corresponding residues present in VanRsc failed to create a protein capable of being activated by VanS of S. coelicolor (VanSsc), which suggests that interaction of the response regulator with its cognate sensor kinase may require a region more extended than the REC domain. A T69S amino acid substitution in the REC domain of VanRst produced a strain exhibiting weak constitutive resistance, indicating that this particular amino acid may play a key role for VanS-independent phosphorylation in the response regulator protein.
ver since the first clinical isolates of pathogenic strains of vancomycin-resistant enterococci (VRE) appeared in the late 1980s (1), the spread of vancomycin resistance through bacterial populations has been an acute public health issue, highlighted by the emergence of vancomycin-and methicillin-resistant Staphylococcus aureus (VRSA) strains in hospitals (2) . Vancomycin inhibits cell wall biosynthesis by binding to the D-alanyl-D-alanine (D-Ala-D-Ala) terminus of lipid-attached peptidoglycan (PG) precursors on the outside of the cytoplasmic membrane. This interaction blocks the formation of mature PG, principally by denying transpeptidase enzymes access to their substrate and thereby preventing the formation of the peptide cross-links between polysaccharide strands that give the cell wall its rigidity (3) . However, reprogramming of cell wall biosynthesis such that the stem pentapeptide of PG precursors terminates in D-alanyl-D-lactate (DAla-D-Lac) rather than in D-Ala-D-Ala can allow the cell to escape the action of vancomycin since the binding affinity of the drug for the new precursors is significantly lower than that for the original precursors (4) (5) (6) . Reprogramming can be achieved via expression of dedicated glycopeptide antibiotic resistance gene clusters minimally consisting of a core of five genes: vanR, vanS, vanH, vanA, and vanX. The polycistronic operon vanHAX encodes the VanH, VanA, and VanX enzymes, which are required for the remodeling of cell wall precursors, and the transcriptional induction of van-HAX is normally regulated by the VanR-VanS two-component system (TCS), which is encoded by the dicistronic operon vanRS (7, 8) .
TCSs are the most dominant type of signal transduction pathway found in prokaryotes and play an important role in the regulation of metabolism in response to different nutritional or environmental signals. At their simplest, TCSs consist of a pair of sensor histidine kinase (SHK) and response regulator (RR) proteins. The SHK responds to a specific inducer signal by modifying the phosphorylation state of the cognate RR. The N terminus of the SHK can be diverse but usually contains a sensory or input domain which responds to changes in environmental stimuli. The C-terminal cytoplasmic kinase of SHK, usually known as a transmitter domain, contains two distinct subdomains: (i) a well-conserved catalytic and ATP binding domain and (ii) a less well conserved dimerization and histidine phosphotransfer domain (9) (10) (11) . The N-terminal part of the RR plays a role in phosphotransfer and possesses a phosphorylation pocket containing three conserved aspartate residues and one lysine residue. Phosphorylation of a conserved aspartate within the phosphorylation pocket by the SHK or potentially also by intracellular phosphate donors, such as acetylphosphate, induces a conformational change in the RR, thereby activating the C-terminal DNA-binding effector domain (DBED), typically converting the RR into an active transcription activator (12) . On exposure to vancomycin, VanS is autophosphorylated using ATP at a conserved C-terminal histidine residue, and the phosphoryl group is then transferred to a conserved aspartate in the N terminus of its cognate RR, VanR (13) . Phospho-VanR has an enhanced C-terminal DBED DNA-binding activity and thereby triggers transcription of the vanHAX genes and confers resistance to vancomycin. Null mutation of the vanR gene consequently always produces a glycopeptide antibiotic-sensitive phenotype, and the level of vancomycin resistance correlates with the expression of the vanHAX genes.
Resistance to vancomycin and other glycopeptide antibiotics has typically been identified in pathogenic bacteria or in nonpathogenic glycopeptide-producing strains. The resistance gene clusters in glycopeptide-producing bacteria are associated with the glycopeptide biosynthetic gene cluster (14) (15) (16) (17) (18) (19) (20) (21) (22) . The model actinomycete Streptomyces coelicolor is a nonpathogenic, non-glycopeptide-producing strain possessing inducible, high-level resistance to vancomycin via expression of a cluster of seven resistance genes, vanSRJKHAX (Fig. 1A) . This cluster is organized into four transcription units (vanRS, vanJ, vanK, and vanHAX) (23) . The role of all genes in this cluster in conferring vancomycin resistance has been characterized in detail (24) (25) (26) (27) (28) (29) (30) . On exposure of S. coelicolor to vancomycin, VanSsc switches from having activity as a phosphatase to functioning as a kinase, and the resulting increase in the abundance of phospho-VanRsc activates transcription from the van promoters, thereby inducing vancomycin resistance (25, 26) . In the absence of inducer drug, the RR VanRsc is activated by the intracellular small-molecule phosphate donor acetylphosphate, but the phosphatase activity of VanSsc acts to suppress the level of phospho-VanR and prevent expression of the resistance genes (Fig. 1A ). An S. coelicolor vanSsc deletion mutant consequently constitutively expresses the van genes (25) . In addition to S. coelicolor, glycopeptide resistance has been explored in several other actinomycetes, including Streptomyces toyocaensis. S. toyocaensis produces a sugarless glycopeptide, A47934, and the resistance genes in this organism are associated with the A47934 biosynthetic cluster (14) . From a total of 34 open reading frames identified in the A47934 cluster, 8 genes (vanSst, vanRst, vanHst, vanAst, vanXst, murX, staP , and staQ [the "st" label is used here to indicate sequences originating in S. toyocaensis]) are predicted to be involved in A47934 resistance (Fig. 1B ) (14) , but molecular genetic studies to understand the biological function of each gene have not been attempted to date.
In this work, we used a combinatorial vanRS gene swapping approach to investigate the distinctive biological role of the individual VanR and VanS protein components in relation to the dif- ferences in glycopeptide inducer specificity present in S. coelicolor and S. toyocaensis. We discuss the insight into the mechanisms directing the immediate response to glycopeptide antibiotics involving sensing by VanS and transduction of the signal from VanS to VanR that the results provide.
MATERIALS AND METHODS
Antibiotics, bacterial strains, and culture conditions. The plasmids and bacterial strains used for this study are listed in Table 1 . Except where described here, the media and culture conditions were those given previously (31, 32) . Vancomycin and teicoplanin solutions were made from commercially available antibiotic powder (Sigma-Aldrich) and used for all bioassays. For bioassays performed using A47934, a neutralized NH 4 OH extract solution of A47934 was prepared from the producer strain, S. toyocaensis, as described previously (19) . No glycopeptide antibiotics were included in any precultures used in any of the experiments.
Construction of vectors. All vectors constructed are listed in Table 1 , and the primer sequences used in their construction are given in Table S1 in the supplemental material. To construct pGN073, a 3.5-kb DNA fragment containing the vanRSsc genes and its native promoter sequence (p-vanRSsc) was obtained by PvuII digestion of S. coelicolor cosmid H66 and then ligated into the EcoRV site of pMS81 (33) . A similar 3-kb DNA fragment containing the vanRSst genes with its own promoter sequence (p-vanRSst) was obtained by SacI digestion of S. toyocaensis cosmid pCep5 (14) and blunt ended by reaction with DNA polymerase I. It was then cloned into pMS81 cut with PvuII to create pHJH2000. pGN067 harboring the vanRsc gene with its own promoter sequence (p-vanRsc) was prepared using an In-Fusion PCR cloning system (Clontech). In order to construct pGN067, a KpnI/NdeI fragment containing the ermE promoter (ermEp) sequence in pHJH2001 was replaced by a PCR product amplified using primers pRsc IF PvuII F and pRsc IF R. The vanRst gene including its own promoter (p-vanRst) was amplified by PCR using primers vanRst I and vanRst II and then cloned into the vector pGEM-T Easy (Promega) to create pHJH2002. After verification of the sequence, a 1.1-kb DNA fragment of p-vanRst was obtained from pHJH2002 by SpeI/PvuII digestion and ligated into the SpeI-PvuII sites of pMS81 to create pHJH2003. The vanSsc gene was obtained by PCR amplification using primers vanSFOR and vanSREV and cloned into pGEM-T Easy, and the sequence was verified by sequencing prior to restriction digestion. The resulting plasmid, pHJH2004, was cut with NdeI to obtain a 1.1-kb DNA fragment of vanSsc, which was then ligated into the NdeI site of pIJ10257 (24) to create pDU001. The vanSst gene was amplified by PCR using primers vanSst I and vanSst II, and the product was cloned into pGEM-T Easy to create pHJH2005. After the sequence of vanSst in pHJH2005 was confirmed, a 1.1-kb NdeI fragment of vanSst was obtained and ligated into the NdeI site of pIJ10257 (24) to create pDU006. To construct pHJH2006, a KpnI/AvrII fragment of vanSst obtained from pDU006 was ligated into pIJ6902 (28) cut with KpnI/XbaI.
Site-directed mutagenesis of VanRst. In order to substitute targeted amino acids in the N-terminal receiver (REC) domain of the VanRst protein for the corresponding residues present in VanRsc, we introduced site-directed nucleotide changes in the vanRst gene to construct recombinant plasmids using a QuikChange site-directed mutagenesis kit (Stratagene) according to the manufacturer's instructions. pGN078, pGN080, pGN081, pGN082, and pGN083 were created using pJG001 (plasmid pIJ10257 harboring vanRst under the control of ermEp) as the template DNA and the following primer pairs listed in Table S1 in the supplemental material: vanRst L10P_M12L and vanRst L10P_M12L_anti for pGN078, vanRst L10P_M12L and vanRst L10P_M12L_anti for pGN080, R106Q_ I109A_I112L and R106Q_I109A_I112L_anti for pGN081, vanRst_S69T and vanRst _S69T_anti for pGN082, and vanRst_V62I and vanRst_ V62I_anti for pGN083. pGN079 was made using pGN078 as the template and the primers R106Q_I109A_I112L and R106Q_I109A_I112L_anti (see Table S1 in the supplemental material). The correct formation of all the mutated vanRst variants was confirmed by sequencing. The required strains (as listed in Table 1 ) were then constructed by conjugal transfer of plasmids from Escherichia coli ET12567(pUZ8002) (31) .
Construction of strains. S. toyocaensis ⌬vanRSst::apr (H31) and ⌬vanSst::apr (H33) mutant strains were constructed by replacing the entire coding sequences of the target gene (or genes) with a cassette carrying the apramycin resistance gene (apr) and oriT of RK2, using a published PCR-targeting method (34) . The primer sequences used are listed in Table  S1 in the supplemental material. The cosmid pCep5 was introduced into E. coli BW25113 carrying pIJ790, and the target gene was disrupted by electroporation of the cells with the PCR-amplified apr-oriT cassette, generated using primers carrying the appropriate gene-specific extensions. Using pIJ773 (34) as the template, the apr disruption cassette was created by PCR using primers vanRst KO I and vanSst KO II for ⌬vanRSst::apr and primers vanSst KO I and vanSst KO II for ⌬vanSst::apr. Each resulting cosmid was then introduced into E. coli ET12567 carrying pUZ8002 and transferred into S. toyocaensis NRRL 15009 by conjugation. Double-crossover integrants were isolated as apramycin-resistant, kanamycin-sensitive colonies. Strain H320 was constructed by introducing the vanSst gene under the control of a constitutive promoter (ermEp-vanSst in pHJH2006 in Table 1 ) into the ⌬vanRSst::apr (H31) mutant background. An unmarked S. coelicolor ⌬vanRsc (H21) deletion mutant was constructed by introducing cosmid H66 ⌬vanRsc::apr into E. coli BT340 and excising the apr-oriT cassette (which is flanked by FLP recombination target sites) via induction of the FLP recombinase system (34) . The resultant mutant cosmid, H66 ⌬vanRsc, was then introduced into S. coelicolor M600 by protoplast transformation, and kanamycin-resistant transformants were selected. After growth in the absence of antibiotic selection, colonies that had lost kanamycin resistance and were sensitive to vancomycin were selected, purified, and then analyzed by PCR to confirm the in-frame replacement of the wild-type sequence by a nonpolar scar sequence. All other S. coelicolor and S. toyocaensis strains created in this study were constructed by conjugal transfer from E. coli strain ET12567(pUZ8002) carrying the appropriate pMS81 or pIJ10257 plasmid derivative. Exconjugants were selected by hygromycin resistance.
Antibiotic susceptibility tests. All the bioassays, including both paper disc diffusion assays and the determination of MICs, using Streptomyces strains were performed on minimal medium plus Casamino Acids, glucose, and tiger milk (MMCGT) agar medium (32) . For the paper disc diffusion assays, approximately 10 5 spores of each strain were spread on 9-cm-diameter round plates, and 6-mm paper discs containing 30 g of glycopeptide antibiotics were then applied to the freshly spread spore lawns (19, 29) . The plates were scored after incubation at 30°C for 2 to 4 days by measuring the diameter of any zone of growth inhibition that formed (referred to as the zone-of-inhibition diameter [ZID]), such that a ZID score of 0 corresponds to complete resistance and ZIDs of Ͻ7 indicate very strong resistance (the diameter of the paper discs used was 6 mm). ZID scores defined as "(0)" correspond to strains displaying growth up to the edge of the antibiotic disc but with a zone of detectably weaker growth around the disc. MIC values were evaluated using a previously described method (29) RNA preparation and qRT-PCR. For the analysis of vanH transcription in response to glycopeptide antibiotics, 0.5 ml of germinated spores of S. coelicolor M600 or S. toyocaensis NRRL 15009 were inoculated in 50 ml NMMP minimal liquid medium (31) and grown to mid-log phase. Immediately after 10 ml of the first sample was taken as a noninduced control (0 min), the glycopeptide antibiotics were added to a final con- centration of 10 g/ml and samples were taken 30, 60, and 90 min after treatment. Culture samples were immediately centrifuged for 10 s at 4,000 ϫ g, and the cell pellet was resuspended in 10 ml of RNAprotect Bacteria solution (Qiagen). After a 5-min incubation at room temperature, the sample was centrifuged again for 10 s at 4,000 ϫ g and the supernatant was discarded. RNA preparation and quantitative real-time reverse transcription-PCR (qRT-PCR) were performed according to methods described previously (35) . For the qRT-PCR of S. coelicolor vanH, we used a pair of previously published primers, qvanH-F and qvanH-R (30), and gene SCO4702 as the internal normalization control (28) . Primer pair qvanHst-F and qvanHst-R for qRT-PCR analysis of S. toyocaensis vanH transcription was designed using Primer3 software (http://frodo.wi.mit .edu/) (see Table S1 in the supplemental material). Gene WP_037929599, which has 94% nucleotide sequence identity to SCO4702, was used as the internal normalization control. qRT-PCR determinations were performed in triplicate with each RNA sample, and average abundances were determined.
RESULTS
Viability in an antibiotic bioassay is a good indicator of the ability of the glycopeptide to induce the VanR-VanS system. The expression of the genes in the vancomycin resistance cluster in wild-type S. coelicolor strain M600 is induced by vancomycin and A47934 but not by teicoplanin (23, 25, 29) . In a paper disc diffusion bioassay, S. coelicolor therefore grows to the edge of discs containing vancomycin or A4794 but is markedly inhibited by teicoplanin, around which, in contrast, a large circular halo of nongrowth is produced ( Fig. 2A) . Consistent with these phenotypes, qRT-PCR analysis indicates that transcription of the vanH gene (a reporter for expression of the vanHAX operon) is highly induced by both vancomycin and A47934 in S. coelicolor but not by teicoplanin, which totally failed to induce transcription even after exposure for 90 min (Fig. 2A) . The maximal induction of vanH by A47934 was approximately half that observed in response to vancomycin, and the MIC observed was also markedly lower. In contrast to S. coelicolor, S. toyocaensis (NRRL 15009), the producer of the glycopeptide antibiotic A47934, was resistant to A47934 but susceptible to both vancomycin and teicoplanin (Fig. 2B) . Quantification of vanH transcription in S. toyocaensis showed strong inducible expression in response to A47934 but not in response to vancomycin or teicoplanin (Fig. 2B) . A low level of vanH transcription was detectable in response to teicoplanin, and this corresponded to a slight reduction in the diameter of the teicoplanin inhibitory halo compared to that obtained with vancomycin in the plate bioassay and an increase in the MIC value (Fig. 2B) . Thus, the viability of the cells in the presence of glycopeptides, as determined by the disc diffusion bioassay and measurement of the MIC, is a good indication of whether the particular antibiotic is a strong, weak, or poor inducer or a noninducer of the resistance controlled by VanR-VanS. A resistance index assigned on the basis of the combined consideration of the zone-of-inhibition diameter (ZID) and MIC bioassay values is used in the subsequent sections as a measure of the activation of a resistance system by a particular antibiotic in a particular strain. Investigating glycopeptide-induced signal transduction through the S. coelicolor and S. toyocaensis VanR-VanS twocomponent systems. The amino acid sequences of the VanS and VanR proteins present in S. coelicolor and S. toyocaensis are highly conserved (90% identity for VanR and 67% identity for VanS), but the mechanism of VanR-VanS signal transduction in each strain is different (Fig. 2) . To investigate glycopeptide-induced signal transduction through the VanR-VanS systems, we constructed S. coelicolor and S. toyocaensis strains carrying all possible pairwise combinations of VanR and VanS from each strain and determined their antibiotic resistance indexes using the panel of three glycopeptide antibiotics, A47934, teicoplanin, and vancomycin ( Fig. 3 ; see also Fig. S1 and S2 in the supplemental material). Since this approach focuses on the resistance phenotypes that are the functional end product of VanR-VanS activation, the readout reports on the combined efficiency of the following processes: detection of the glycopeptide by the VanS sensor, transduction of the activation signal from VanS to VanR by phosphorylation, induction of expression from the van gene promoters, and translation of the van gene transcripts to produce functional enzymes. The level of phospho-VanR can be influenced by both phosphorylation and dephosphorylation. Strains using S. coelicolor as the host were constructed on the basis of unmarked inframe deletion mutants in which the coding sequence for the vanR (this study), vanS (25) , or vanRS (25) genes had been removed. Genes were added back into these mutants in a single copy to produce the required combinations by using vectors that integrate stably into the chromosome at the BT1 attachment site (33) . A similar strategy was used for the S. toyocaensis strains, except that these were based on deletion mutants in which the coding sequence of vanS or vanRS had been replaced by an apramycin resistance cassette and genes were added in a single copy at the BT1 and C31 integration sites to produce all the combinations. All strains constructed grew in the absence of antibiotics as vigorously as their parental strains, with the exception of the S. coelicolor ⌬vanSsc and S. toyocaensis ⌬vanSst strains expressing vanRsc (H2473, H2297, and H2311), which exhibited reduced growth. These three strains, however, showed higher than expected levels of resistance in the glycopeptide antibiotic tests (see below), and the growth defects were therefore not significant in this context.
(i) Glycopeptide antibiotic inducer specificity depends on the identity of the VanR-VanS two-component system rather than the host background. Introduction of the S. toyocaensis
vanRS genes (vanRSst) into the S. coelicolor ⌬vanRSsc-null mutant (producing strain H2060) switched the natural inducer specificity of S. coelicolor to that of S. toyocaensis; i.e., it was resistant to A47934 but sensitive to vancomycin and teicoplanin ( Fig. 3A ; see also Fig. S1e in the supplemental material) . Similarly, introduction of the S. coelicolor vanRS genes (vanRSsc) into the S. toyocaensis ⌬vanRSst-null mutant (producing strain H2360) also switched the inducer specificity so that the resulting S. toyocaensis strain was, like wild-type S. coelicolor, resistant to vancomycin and A47934 but sensitive to teicoplanin ( Bioassay analyzing the activities of three selected glycopeptide antibiotics, A47934 (A), teicoplanin (T), and vancomycin (V), and their MICs against S. coelicolor M600 (A) and S. toyocaensis NRRL 15009 (B). Paper discs containing 30 g of each antibiotic were placed on freshly spread lawns of each strain, and the plates were incubated for 2 days at 30°C. A clear and strong dark-colored halo around the paper discs indicates the zone of inhibition. The corresponding antibiotic ZID and MIC values are presented below the bioassay plates, together with graphs quantifying the response to each antibiotic according to the level of vanH transcription in each strain determined by qRT-PCR. Cells were grown to mid-exponential phase in NMMP liquid medium and exposed to 10 g/ml of each antibiotic. Total RNAs were extracted from samples taken immediately before the addition of antibiotic (time zero) and at subsequent 30-min intervals up to 90 min (i.e., at 30, 60, and 90 min). The x axis indicates the time (in minutes) after addition of the antibiotic, and the y axis shows the fold change in normalized vanH transcript abundance calculated relative to the abundance at time zero, which was defined as 1. biotics regardless of the host background ( Fig. 3 ; see also Fig. S1f and n in the supplemental material). In contrast, the reciprocal noncognate combination of VanRsc and VanSst was productive. Strains H36 (S. coelicolor background) and H2309 (S. toyocaensis background) were both resistant to A47934 but susceptible to vancomycin and teicoplanin ( Fig. 3 ; see also Fig. S1g and m in the supplemental material). The inducer specificity toward the glycopeptide antibiotics is therefore again determined according to the origin of the VanS sensor (VanSst) and not the host background. Interestingly, however, both H36 and H2309 also exhibited significantly increased resistance toward teicoplanin (see Fig. S1g and m in the supplemental material). These results are consistent with cross talk between VanRsc and VanSst in responding to the presence of glycopeptide antibiotics and, interestingly, also suggest that VanRsc may, under some conditions, act as a better RR partner for VanSst than its natural cognate partner, VanRst.
(iii) VanRst is apparently not activatable by the intracellular phosphate donor acetylphosphate. S. coelicolor ⌬vanSsc (H2473) exhibits significantly increased resistance to all three glycopeptide antibiotics relative to that of the ⌬vanRSsc strain ( Fig. 3A ; see also Fig. S1d in the supplemental material) . This was shown to be associated with the constitutive but moderate level of expression of the van resistance reporter gene vanH even in the absence of any glycopeptide (see Fig. S3 in the supplemental material). In contrast, S. toyocaensis ⌬vanSst (H2118) was susceptible to A47934 and did not exhibit constitutive resistance to any of the antibiotics tested ( Fig. 3B ; see also Fig. S1k in the supplemental material) . The wild-type resistance phenotype was fully restored in this strain by addition of a single integrated copy of vanSst, excluding the possibility of any polar effect of vanSst deletion (data not shown). S. coelicolor VanS (VanSsc) is known to negatively regulate the VanRsc function in the absence of an inducer drug, such that an S. coelicolor vanS-null mutant (the ⌬vanSsc mutant) exhibited constitutive resistance via the phosphorylation of VanRsc, which is dependent upon acetylphosphate production (25) . The absence of a similar constitutive glycopeptide resistance phenotype in S. toyocaensis ⌬vanSst implies that VanRst cannot be phosphorylated in a VanSst-independent manner. Introduction of vanRsc into S. toyocaensis ⌬vanRSst (producing strain H2311) produced a constitutive resistance phenotype ( Fig. 3B ; see also Fig. S2f in the supplemental material), consistent with the acetylphosphate-dependent phosphorylation of VanRsc taking place in this strain background, as in the native host S. coelicolor strain. In contrast, the introduction of vanRst into the S. coelicolor ⌬vanRSsc (producing strain H2062) or S. toyocaensis ⌬vanRSst (producing strain H2476) background yielded strains which were susceptible to all three glycopeptide antibiotics ( Fig. 3 ; see also Fig. S2c and e in the supplemental material, respectively), suggesting that phosphory- 
toyocaensis).
Resistance indexes were determined from the ZID (in millimeters) and MIC (in micrograms per milliliter) values, as described in Materials and Methods, and the keys to these categories are presented beneath each table. The genotypes of all strains are described in detail in Table 1 , and the data from which the indexes are derived are presented in Fig. S1 and S2 in the supplemental material.
lation of VanRst using acetylphosphate as the substrate is inefficient. S. coelicolor strain H2297 (see Fig. S2b in the supplemental material) carrying a copy of vanRsc at the BT1 integration site exhibited the same phenotype as strain H2473 (see Fig. S1d in the supplemental material), where vanRsc is present at its native location and served as a control for the genetic location of the vanR expression constructs.
Site-directed mutagenesis of the N-terminal REC domain of VanRst to more resemble the VanRsc REC domain fails to produce an activatable VanSsc protein but creates a variant subject to VanS-independent activation. The specificity of SHK-RR interactions is believed to be determined by coevolving residues located in the N-terminal dimerization and histidine phosphotransfer (DHp) domain of the SHK and in the receiver (REC) domain of the RR (36, 37) . Mutation of these coevolving residues either in the SHK or in the RR can allow the specificity of the cognate pairs to be rewired, as previously shown with two closely related SHK-RR systems in Escherichia coli, EnvZ-OmpR and RstB-RstA (37, 38) . In this work, the VanRst-VanSsc RR-SHK pairing failed to induce glycopeptide resistance in either the S. coelicolor or the S. toyocaensis strain background, suggesting an imperfect interaction between the VanRst and VanSsc proteins. The REC domains of VanRsc and VanRst differ by only 8 amino acid residues, however, so we attempted to improve this interaction by gradually altering the amino acids in VanRst to correspond to those found in VanRsc using site-directed mutagenesis (Fig. 4) . The activity of the mutagenized vanRst variants was tested by single-copy integration into the S. coelicolor ⌬vanRsc and S. toyocaensis ⌬vanRst strain backgrounds, assessing the phenotype of resistance of the resulting strains toward A47934, teicoplanin, and vancomycin. None of the mutations in VanRst tested restored resistance to wild-type levels when paired with VanSsc in S. coelicolor ( Fig. 5A ; see also Fig. S4 in the supplemental material) , but all were functional in restoring A47934 resistance when used with their natural VanSst partner in S. toyocaensis ( 
DISCUSSION
In many bacterial glycopeptide antibiotic resistance systems, the important role of recognizing the presence of the antibiotic and transducing an appropriate signal to the chromosome is performed by a VanR-VanS two-component system, but relatively little is known about how the two proteins involved cooperate to achieve this. In this work, we exploited the different responses to glycopeptide antibiotics exhibited by the VanR-VanS sensory systems in two streptomyces strains, Streptomyces coelicolor and Streptomyces toyocaensis, to explore this area and to define the functioning of each protein in each strain background. The A47934 resistance gene cluster in S. toyocaensis was first identified and reported in 2002 (14) , but the molecular mechanism of A47934 resistance as well as the functioning of its key regulatory two-component system, VanRst-VanSst, has remained poorly defined. This study is the first to investigate this system and compared its activity with that of the analogous and well-characterized two-component system from S. coelicolor, VanRsc-VanSsc (25, 26) .
Notably, exchanging just the complete VanR-VanS two-component system between the two Streptomyces strains was sufficient to switch the glycopeptide resistance profiles. The resistance profiles were therefore determined by the differences between the amino acid sequences of the VanR-VanS proteins present rather than by inherent differences in cell wall structure or biosynthesis between the strains. The activity of extracellular D,D-carboxypeptidases has been shown to alter the efficacy of glycopeptide antibi- (39) , but the difference in the control by VanR-VanS is clearly the dominant factor differing between S. coelicolor and S. toyocaensis. The incomplete restoration of resistance to vancomycin in S. toyocaensis H2360 (⌬vanRSst vanRSsc) compared to the level of resistance of wild-type S. coelicolor could, however, suggest some contribution from differences in carboxypeptidase activity between strains, but this could also be due to a possible increase in the level of expression of staP from the A47934 cluster, which is known to have deleterious effects on growth (29) . The ability to predictably alter the glycopeptide resistance profiles by swapping the VanR-VanS systems strongly supports the proposal that VanS responds directly to an antibiotic ligand such that VanSst is able to sense and interact productively with A47923 but not with teicoplanin or vancomycin, whereas VanSsc interacts productively with vancomycin or A47934 but not with teicoplanin.
Gene swaps producing hybrid combinations of either VanRscVanSst or VanRst-VanSsc as the sole sensory system for glycopeptides produced results which indicate differences in the activities of the two RR proteins. VanRsc was able to transduce the signal detected by VanSst in both the S. coelicolor and S. toyocaensis backgrounds (producing strains H36 and H2309), while VanRst was unable to accomplish this in either background when similarly paired with VanSsc (producing strains H2123 and H3129) ( Fig. 3 ; see also Fig. S1 in the supplemental material) . In addition to being unable to interact productively with VanSsc, VanRst was found to be different from VanRsc in being resistant to VanS-independent activation. In S. coelicolor, VanRsc can be activated in the absence of VanSsc by phosphorylation that is dependent upon the ackA (SCO5424) and pta (SCO5425) genes required for acetylphosphate production (25) (see H2473 or H2297 in Fig. 3A ; see also Resistance indexes were determined from the ZID (in millimeters) and MIC (in micrograms per milliliter) values, as described in Materials and Methods, and the keys to these categories are presented beneath each table. The genotype of all strains is described in detail in Table 1 , and the data from which the indexes are derived are presented in Fig. S4 and S5 in the supplemental material.
ties to the S. coelicolor sequences, respectively), and VanRsc can also be activated independently of VanS in this strain background (H2311 in Fig. 3B ; see also Fig. S2f in the supplemental material) . The absence of VanS-independent activation of VanRst in S. toyocaensis is therefore consistent with acetylphosphate being a poor net phosphate donor for VanRst. Response regulators can exhibit wide differences in the half-lives of their phosphorylated forms, and it is possible that the half-life of phospho-VanRst is short compared to that of phospho-VanRsc. The antibiotic resistance phenotypes of the strains in which VanSst is partnered with VanRsc also indicate that, in common with VanSsc, VanSst must possess phosphatase activity, in addition to its kinase function (H36 and H2309 in Fig. 3 ; see also Fig. S1g and m in the supplemental material). If this were not the case, these strains would exhibit the same constitutive resistance to all three antibiotics shown by strains H2297 and H2311. Although VanSst in S. toyocaensis has retained the phosphatase activity seen in the S. coelicolor system, it is evidently not required for keeping expression of the resistance genes to a minimum in the absence of glycopeptide inducers, since VanRst is not phosphorylated independently of VanS.
It is noteworthy that VanRsc and VanRst behave so differently when their amino acid sequences, particularly in their REC domains, are highly similar (90% identity; Fig. 4 ). Although not exhaustive, the results of site-directed mutagenesis targeting the Nterminal REC domain of VanRst suggest that additional sequences outside this region may be important for correct interaction with the VanS kinases and go against the general belief that this domain of RRs is the only region responsible for the interaction with a cognate SHK partner. Barbieri et al. (2010) previously demonstrated that the extent of the interdomain interface made by the REC domain with the DBED in several RRs from the OmpR/PhoB family influenced the rate of phosphotransfer from acetylphosphate in vitro (40) . Proteins with substantial interdomain interfaces phosphorylate poorly, possibly because the interdomain interactions stabilize an inactive conformation of the RR which is not catalytically competent to accept phosphate from acetylphosphate (40) . Although the authors have shown that the interdomain interaction did not influence the rate of phosphotransfer from the cognate SHK, this might not be necessarily true for a noncognate SHK. Our in vivo experiments show that in contrast to VanRsc, VanRst does not efficiently undergo phosphorylation using acetylphosphate. While this could be due to a very short halflife of the phosphorylated form, it is also consistent with unphosphorylated VanRst occupying a conformation where the REC domain and DBED are in tighter contact than they are in VanRsc, thus preventing the acceptance of phosphate from acetylphosphate. Such structural differences between VanRsc and VanRst could also be responsible for the different promiscuities with respect to phosphorylation by cognate or noncognate SHKs. We hypothesize that VanRst requires a very precise interaction with the SHK in order to release the inactive conformation putatively stabilized by substantial interdomain contact between the REC domain and DBED. This requirement would restrict the specificity of VanRst only to its cognate SHK, VanSst. In contrast, VanRsc evidently occupies a conformation more amenable to phosphorylation using acetylphosphate, also making it generally more accessible for activation by a noncognate SHK. Interestingly, the VanRst mutant variant VanRst(T69S) is more readily activatable in the absence of VanSst (or VanSsc) than the wild-type sequence, and strains expressing this variant in these genetic backgrounds exhibit a similar constitutive but low-level glycopeptide resistance (see H2329 and H2338 in Fig. 5 ; see also Fig. S5d and k in the supplemental material).
The investigation of vancomycin resistance in bacteria has been the subject of extensive research, and considerable effort has been put into studying the VanR-VanS TCS in particular, mostly using pathogenic VRE strains as a model system. A detailed topological understanding of how the phosphorelay system in the VanR-VanS complex operates has, however, remained elusive due to a lack of structural data. Understanding the interplay between the VanS effector ligand on the one hand and the downstream activation of VanR by VanS on the other will be important for the development of future strategies for circumventing inducible glycopeptide antibiotic resistance in clinical infections. Furthermore, TCSs are one of the most abundant and ubiquitous adaptive signal transduction pathways present in bacteria, making them attractive targets for the modulation of bacterial function by novel bioactive molecules, particularly in pathogenic strains.
